会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 18. 发明授权
    • Substituted acetophenones useful as PDE4 inhibitors
    • 用作PDE4抑制剂的取代苯乙酮
    • US08148537B2
    • 2012-04-03
    • US12520325
    • 2007-12-21
    • Jakob FeldingSimon Feldbæk Nielsen
    • Jakob FeldingSimon Feldbæk Nielsen
    • C07D213/46A61K31/435
    • C07D213/61C07D413/12C07D417/12
    • The present invention relates to a compound according to formula: (I); wherein X1, X2, X3, X4 and X5 independently of each other represent —CH— or N; or X3, X4 and X5 independently of each other represent —CH— or N, and Xi and X2 independently of each other represent C and form part of an additional 6-membered aromatic ring; R1 represents hydrogen, alkyl, alkenyl, alkynyl, haloalkyl, hydroxyalkyl, or alkylcarbonyl, all of which are optionally substituted; R2 and R3 independently represent hydrogen, —CH2—C(O)NR—R′, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, haloalkyl, hydroxyalkyl, heterocycloalkenyl, alkylaryl, alkylalkoxycarbonyl, alkylcarbonyloxy, or alkoxyalkyl, all of which are optionally substituted; R11 represents hydrogen, halogen, cyano, amino, alkoxy or alkylamino, X1-X5 represent —CH— or N, including N-oxides, enantiomers and diastereomers; and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention relates further to processes for the preparation of said compounds, to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.
    • 本发明涉及式(I)化合物: 其中X1,X2,X3,X4和X5彼此独立地表示-CH-或N; 或X3,X4和X5彼此独立地表示-CH-或N,并且X 1和X 2彼此独立地表示C并且形成另外的6元芳环的一部分; R 1表示氢,烷基,烯基,炔基,卤代烷基,羟基烷基或烷基羰基,它们均为任选取代的; R2和R3独立地表示氢,-CH2-C(O)NR-R',烷基,环烷基,烯基,环烯基,炔基,卤代烷基,羟基烷基,杂链烯基,烷基芳基,烷基烷氧基羰基,烷基羰氧基或烷氧基烷基, ; R 11表示氢,卤素,氰基,氨基,烷氧基或烷基氨基,X 1 -X 5表示-CH-或N,包括N-氧化物,对映体和非对映体; 及其药学上可接受的盐,水合物或溶剂化物。 本发明进一步涉及制备所述化合物,所述化合物用于治疗的方法,包含所述化合物的药物组合物,治疗疾病的方法。 所述化合物的皮肤病,以及所述化合物在制备药物中的用途。
    • 19. 发明申请
    • TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES
    • 作为磷酸二酯酶抑制剂治疗牙齿疾病的三唑吡啶
    • US20100113442A1
    • 2010-05-06
    • US12595922
    • 2008-04-16
    • Jakob FeldingMorten Dahl Sornesen
    • Jakob FeldingMorten Dahl Sornesen
    • A61K31/437C07D471/04A61K31/5377A61K31/497A61P35/00A61P17/02A61P17/10
    • C07D471/04A61K31/437
    • The present invention relates to a compound according to formula (I), wherein X and Y are either C and N or N and C; Z is CH2, CH2—CH2, CH2—NH, or NH; R1 is halogen, or R1 is alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, cycloalkyl, alkoxycarbonyl, aryl, all of which are optionally substituted; R2 is hydrogen, or R2 is alkyl, cycloalkyl, alkoxy, heterocycloalkyl, aryl, heteroaryl, alkoxycarbonyl, aminocarbonyl, amino, all of which are optionally substituted; A is aryl, cycloalkyl, cycloalkenyl, heteroaryl, heterocycloalkyl or heterocycloalkenyl, all of which are optionally substituted; and pharmaceutically acceptable salts, hydrates, or solvates hereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments, in particular for the treatment of dermal diseases.
    • 本发明涉及式(I)化合物,其中X和Y为C和N或N和C; Z是CH 2,CH 2 -CH 2,CH 2 -NH或NH; R1是卤素,或R1是烷基,烯基,炔基,卤代烷基,烷氧基,环烷基,烷氧基羰基,芳基,它们都是任选被取代的; R2是氢,或R2是烷基,环烷基,烷氧基,杂环烷基,芳基,杂芳基,烷氧基羰基,氨基羰基,氨基,它们都是任选被取代的; A是芳基,环烷基,环烯基,杂芳基,杂环烷基或杂环烯基,它们都是任选被取代的; 和其药学上可接受的盐,水合物或溶剂合物。 本发明还涉及用于治疗的所述化合物,包含所述化合物的药物组合物,治疗疾病的方法,例如, 所述化合物的皮肤病,以及所述化合物在制备药物中的用途,特别是用于治疗真皮疾病。
    • 20. 发明授权
    • 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
    • 4-苯基-1-哌嗪基,哌啶基和四氢吡啶基衍生物
    • US07074796B2
    • 2006-07-11
    • US10186339
    • 2002-06-27
    • Benny Bang-AndersenJan KehlerJakob Felding
    • Benny Bang-AndersenJan KehlerJakob Felding
    • A61K31/496C07D403/06
    • C07D215/227C07D209/08C07D209/30C07D217/06C07D295/073
    • The present invention relates to substituted 4-phenyl-1-piperazinyl derivatives having the formula I wherein W is C, CH or N, and the dotted line emanating from W indicates a bond when W is C and no bond when W is N or CH; R1 and R2 are independently selected from hydrogen and halogen, provided at least one of R1 and R2 is a halogen atom; R3 is selected from hydrogen, halogen, C1-6 alkyl, trifluoromethyl, C1-6 alkoxy, aryloxy, aralkoxy, hydroxy, amino, C1-6 alkylamino, di(C1-6 alkyl)amino, nitro and cyano n is 2, 3, 4 or 5; X is CH2, O, S, CO, CS, SO or SO2; and Q is a group of formula wherein Z is a chain of 3 to 4 chain members; wherein the chain members are selected from C, CH, CH2, CO, N and NH, provided that only one of the chain members may be N or NH, and said chain optionally containing one or two double bonds; hvad med acyl?? R4, R5, R6, R7, R8, R9 and R10 are independently selected from hydrogen, halogen, C1-6 alkyl, trifluoromethyl, C1-6 alkoxy, hydroxy, amino, C1-6 alkylamino, di(C1-6 alkyl)amino nitro and cyano; provided that X is not O or S when the group Q is attached via an N atom; and any of its enantiomers and acid addition salts thereof. These compounds have high affinity for D4 receptors.
    • 本发明涉及具有式I的取代的4-苯基-1-哌嗪基衍生物,其中W是C,CH或N,当W是C时,由W发出的虚线表示键,当W是N或CH时,没有键 ; R 1和R 2独立地选自氢和卤素,条件是R 1和R 2中的至少一个和/或 >是卤原子; R 3选自氢,卤素,C 1-6烷基,三氟甲基,C 1-6烷氧基,芳氧基,芳烷氧基,羟基, 氨基,C 1-6烷基氨基,二(C 1-6烷基)氨基,硝基和氰基n为2,3,4或5; X是CH 2,O,S,CO,CS,SO或SO 2; Q为下式的基团,其中Z为3至4个链成员的链; 其中链成员选自C,CH,CH 2,CO,N和NH,条件是链中只有一个可以是N或NH,并且所述链任选地含有一个或两个双 债券 hvad med acyl? R 4,R 5,R 6,R 7,R 8, R 9和R 10独立地选自氢,卤素,C 1-6烷基,三氟甲基,C 1-6烷基, 羟基,氨基,C 1-6烷基氨基,二(C 1-6烷基)氨基硝基和氰基; 条件是当基团Q经由N原子连接时,X不为O或S; 及其任何对映异构体及其酸加成盐。 这些化合物对D 4 S受体具有高亲和力。